10x Genomics has pioneered commercialization of single cell sequencing. We made our first investment in 10x Genomics in the Series A financing in November of 2013. At that time, the company had proof of concept, what we believed was a world-class leadership team, and a clear path to product launch. Throughout the course of a year the 10x Genomics management team continuously executed each milestone. In December of 2014 Foresite Capital lead the $55 million Series B financing to further support the company’s product launch and further development. 10x Genomics launched the GemCode platform in February of 2015 at the Advances in Genome Biology and Technology (AGBT) meeting. AGBT is recognized as the cornerstone for the genomics community and the 10x Genomics launch was highly anticipated and enthusiastically received by industry and the financial community. Since its launch 10x has introduced several additional products and started to rapidly grow sales over the last year. We expect 10x to continue to be a leading innovator in the field of cell sequencing over the next decade.

Previous Portfolio